NCT06821620

Brief Summary

The risk version of the MTNR1B gene (which codes for a melatonin receptor) has been associated with type II diabetes (T2D) and associated physiological markers. People with the risk version of the gene have reduced secretion of insulin when melatonin levels are high (between evening and morning) and impaired glucose tolerance when they eat late. Previous research suggests eating a protein enriched breakfast can improve glucose response. Therefore, the present study will investigate if the version of the MTNR1B gene that people have is associated with their glucose response after breakfast. Also, whether a protein enriched breakfast improves glucose response in participants with the risk version of the gene. Measures of glucose response collected over the two-week duration of the study will be compared between groups with the different versions of the gene. These findings can be used to provide personalised nutrition advice which may reduce the risk of T2D.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 1, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

September 9, 2024

Completed
5 months until next milestone

First Posted

Study publicly available on registry

February 12, 2025

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2025

Completed
Last Updated

May 16, 2025

Status Verified

May 1, 2025

Enrollment Period

6 months

First QC Date

August 1, 2024

Last Update Submit

May 15, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Glucose response

    Area under the curve

    120 minutes

Secondary Outcomes (3)

  • CGM metrics - mean glucose

    14 days

  • CGM metrics - Time in range

    14 days

  • CGM metrics - glycaemic variability

    14 days

Study Arms (2)

Protein enriched breakfast

EXPERIMENTAL
Dietary Supplement: Breakfast

High carbohydrate breakfast

ACTIVE COMPARATOR
Dietary Supplement: Breakfast

Interventions

BreakfastDIETARY_SUPPLEMENT

Breakfast in one condition will be high carbohydrate and in the other protein enriched

High carbohydrate breakfastProtein enriched breakfast

Eligibility Criteria

Age18 Years - 48 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • aged 18-48 years\*, not diabetic, not sleep disorder, not relevant medication (weight loss, sleeping, melatonin), not restricted diet, not allergic to oats, milk, wheat, barley or soya, not implanted medical device, such as pacemakers.

You may not qualify if:

  • aged \< 18 or \> 48 years, diabetic, sleep disorder, eating disorder, taking relevant medication (weight loss, sleeping, melatonin), following a restricted diet, implanted medical device, such as pacemakers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Mary's University

London, United Kingdom

Location

MeSH Terms

Conditions

Glucose Metabolism Disorders

Interventions

Breakfast

Condition Hierarchy (Ancestors)

Metabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

MealsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Breakfast condition - high carbohydrate or protein enriched
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 1, 2024

First Posted

February 12, 2025

Study Start

September 9, 2024

Primary Completion

February 28, 2025

Study Completion

February 28, 2025

Last Updated

May 16, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations